Christopher F. Wyatt - 13 Feb 2025 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role: SVP & Controller
Signature: /s/ Kevin A. Ball, Attorney-in-Fact
Issuer symbol: HCA
Transactions as of: 13 Feb 2025
Transactions value $: -$73,076
Form type: 4
Filing time: 18 Feb 2025, 19:41:24 UTC
Previous filing: 30 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCA	Common Stock	Award	$0	+845	+2.09%	$0.00	41.3K	13 Feb 2025	Direct	F1
transaction	HCA	Common Stock	Tax liability	-$73.1K	-227	-0.55%	$321.92	41.1K	13 Feb 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On January 28, 2022, the reporting person was granted 1,630 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2022-2024. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2022-2024 earnings per share, the number of performance share units that vested equaled 51.9% of the units granted.

Content

On January 28, 2022, the reporting person was granted 1,630 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2022-2024. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2022-2024 earnings per share, the number of performance share units that vested equaled 51.9% of the units granted.